Octaplex 500 IU, powder and solvent for solution for injection, 1 vial

Composition: Human prothrombin complex concentrate containing Factors II, VII, IX, X, as well as the inhibitor, protein C, and its cofactor protein S. Indication: Octaplex is used to treat and prevent bleeding caused by medicines called vitamin K antagonists (such as warfarin). Octaplex is used when rapid correction of the shortage is required in people born with a shortage of the vitamin K dependent clotting factors II and X. It is used when purified specific clotting factor product is not available.

PEMETREXED 500mg, Concentrate for Solution for Injection, 1 Vial

Composition: Pemetrexed 500mg Indication: Pemetrexed Accord is a medicine used in the treatment of cancer. Pemetrexed Accord is given in combination with cisplatin, another anti-cancer medicine, as treatment for malignant pleural mesothelioma, a form of cancer that affects the lining of the lung, to patients who have not received prior chemotherapy. Pemetrexed Accord is also given in combination with cisplatin for the initial treatment of patients with advanced stage of lung cancer. Pemetrexed Accord can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy. Pemetrexed Accord is also a treatment for patients with advanced stage of lung cancer whose disease has progressed after other initial chemotherapy has been used.

RESINCALCIO, Powder for Oral Suspension, 400g

Composition: Calcium polystyrene sulphonate 99.75g/100g Indication: Resincalcio contains calcium polystyrene sulphonate, calcium polystyrene sulphonate, is an Ion exchange rosin that Is used in the treatment of hyperkalemia which acts by decreasing the concentration of potassium ions in the blood. Resincalcio is indicated in the treatment and prevention of hyperkalemia (elevated levels of potassium in the blood)

SUPERFLOX 500mg, 10 Tablets

Composition: Ciprofloxacin 500mg Indication:

Surfactante B Richet 200mg, Intratracheal Suspension

Composition: Bovine lung surfactant 200 mg (25 mg/ml): Indication: Surfactant Richet B is indicated for the prevention and treatment of the Respiratory Distress Syndrome (RDS or Hyaline Membrane Syndrome) in premature infants, reducing the incidence, mortality and complications caused by this syndrome.

Temozolomide Accord 100mg, 5 Hard Capsules

Composition: Temozolomide 100mg Indication: Temozolomide is an anti-cancer medicine. Temozolomide Accord capsules are taken to treat specific forms of brain tumors: Adults with newly diagnosed specific form of brain tumor (glioblastoma multiforme). Temozolomide is first used together with radiotherapy (concomitant phase of treatment) and after that alone (monotherapy phase of treatment). Children 3 years and older and adult patients with specific forms of brain tumor (e.g. glioblastoma multiforme or anaplastic. astrocytoma) that has returned or where the cancer has spread after standard therapy.

Temozolomide Accord 20mg, 5 Hard Capsules

Composition: Temozolomide 20mg Indication: Temozolomide is an anti-cancer medicine. Temozolomide Accord capsules are taken to treat specific forms of brain tumors: Adults with newly diagnosed specific form of brain tumor (glioblastoma multiforme). Temozolomide is first used together with radiotherapy (concomitant phase of treatment) and after that alone (monotherapy phase of treatment). Children 3 years and older and adult patients with specific forms of brain tumor (e.g. glioblastoma multiforme or anaplastic. astrocytoma) that has returned or where the cancer has spread after standard therapy.

Temozolomide Accord 250mg, 5 hard capsules

Composition: Temozolomide 250mg Indication: Temozolomide is an anti-cancer medicine. Temozolomide Accord capsules are taken to treat specific forms of brain tumors: Adults with newly diagnosed specific form of brain tumor (glioblastoma multiforme). Temozolomide is first used together with radiotherapy (concomitant phase of treatment) and after that alone (monotherapy phase of treatment). Children 3 years and older and adult patients with specific forms of brain tumor (e.g. glioblastoma multiforme or anaplastic. astrocytoma) that has returned or where the cancer has spread after standard therapy.

Wilate 500, Powder for preparation of a solution for intravenous injection, 1 Vial

Composition: 500 IU human coagulation Factor VIII Indication: Wilate belongs to the pharmacotherapeutic group of medicines called cloning factors and contains human blood coagulation factor VIII (FVIII) and von Willebrand factor (VWF). Together these two proteins are involved in blood clotting. Wilate is used to treat and prevent bleeding in patients with van Willebrand disease (VWD), which in fact is a family of related diseases. All types of W/0 are inborn. where bleeding can go on for longer than expected. This is either due to a lack of WIF in the blood or due to WJF that does not work the way it should. Wilate is used to treat and prevent bleeding in patients with hemophilia A. This is a condition in which bleeding can go on for longer than expected. It is due to an inborn lack of FVIII in the blood.

ZOLEDRONIC ACID ACCORD 4mg/5ml , Concentrate for Solution for Infusion, 1 vial

Composition: Zoledronic Acid 4mg/5ml Indication: The active substance in Zoledronic Acid Accord is zoledronic acid, which belongs to a group of substances called bisphosphonates. Zoledronic acid works by attaching itself to the bone and slowing down the rate of bone change. It is used: • To prevent bone complications, e.g. fractures, in adult patients with bone metastases (spread of cancer from primary site to the bone). • To reduce the amount of calcium in the blood in adult patients where it is too high due to the presence of a tumour. Tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased. This condition is known as tumour-induced hypercalcaemia (TIH).